In last trading session, Compass Pathways Plc ADR (NASDAQ:CMPS) saw 1.92 million shares changing hands with its beta currently measuring 2.12. Company’s recent per share price level of $3.88 trading at -$0.05 or -1.27% at ring of the bell on the day assigns it a market valuation of $360.26M. That closing price of CMPS’s stock is at a discount of -120.1% from its 52-week high price of $8.54 and is indicating a premium of 42.01% from its 52-week low price of $2.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.74 million shares which gives us an average trading volume of 2.52 million if we extend that period to 3-months.
For Compass Pathways Plc ADR (CMPS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.22. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Compass Pathways Plc ADR’s shares saw a change of -45.51% in year-to-date performance and have moved 4.30% in past 5-day. Compass Pathways Plc ADR (NASDAQ:CMPS) showed a performance of -16.38% in past 30-days. Number of shares sold short was 5.29 million shares which calculate 3.58 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 23 to the stock, which implies a rise of 83.13% to its current value. Analysts have been projecting 23 as a low price target for the stock while placing it at a high target of 23. It follows that stock’s current price would drop -492.78% in reaching the projected high whereas dropping to the targeted low would mean a loss of -492.78% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 32.95% while estimates for its earnings growth in next 5 years are of 16.96%.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
Insiders are in possession of 13.64% of company’s total shares while institution are holding 56.03 percent of that, with stock having share float percentage of 64.88%. Investors also watch the number of corporate investors in a company very closely, which is 56.03% institutions for Compass Pathways Plc ADR that are currently holding shares of the company. TCG CROSSOVER MANAGEMENT, LLC is the top institutional holder at CMPS for having 3.86 million shares of worth $23.3 million. And as of 2024-06-30, it was holding 5.6427 of the company’s outstanding shares.
The second largest institutional holder is CITADEL ADVISORS LLC, which was holding about 3.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.3652 of outstanding shares, having a total worth of $22.16 million.
On the other hand, ARK ETF Trust-ARK Genomic Revolution ETF and iShares Trust-iShares Biotechnology ETF are the top two Mutual Funds which own company’s shares. As of Jun 30, 2025 , the former fund manager was holding 1.61 shares of worth $6.25 million or 1.72% of the total outstanding shares. The later fund manager was in possession of 365.98 shares on May 31, 2025 , making its stake of worth around $1.42 million in the company or a holder of 0.39% of company’s stock.
